Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company engages in the research and development of pharmaceutical products in India and internationally.
Sun Pharma Advanced Research Company Limited, is a listed public company incorporated on 01 March, 2006. It is classified as a public limited company and is located in , . It's authorized share capital is INR 42.50 cr and the total paid-up capital is INR 32.45 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Bhavna Gautam Doshi | 00400508 | 11 years |
Director | Rajamannar Thennati
Shareholder
|
01415412 | 18 years |
Director | Ferzaan Nariman Engineer | 00025758 | 8 years |
Director | Robert Jay Spiegel | 08739625 | 5 years |
Director | Dilip Shantilal Shanghvi
Shareholder
|
00005588 | 19 years |
Additional Director | Venkateswarlu Jasti | 00278028 | 0 years |
Additional Director | Rekha Gopal Warriar | 08152356 | 0 years |
Director | Vidhi Dilip Shanghvi | 06497350 | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 200.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 25.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
SPARCLIFE Inc. | United States | - | - |
Read more
The incorporation date of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is 01 March, 2006
The authorized share capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is INR ₹ 42.5 Cr.
The paid-up capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is INR ₹ 32.5 Cr.
The registered address of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli – Vadodara Highway, Vadodara, Manjusar, Gujarat, India, 391775 - 391775
The CIN number of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is L73100GJ2006PLC047837.